{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T18:18:29Z","timestamp":1788459509007,"version":"build-2803163510"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004206","name":"The University of Osaka","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004206","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pituitary"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1007\/s11102-026-01714-5","type":"journal-article","created":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T18:03:20Z","timestamp":1782929000000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["GH responsiveness to corticotropin-releasing hormone identifies corticotroph-like somatotroph adenomas in acromegaly"],"prefix":"10.1007","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-0167-254X","authenticated-orcid":false,"given":"Hirotaka","family":"Itoh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9365-5561","authenticated-orcid":false,"given":"Kosuke","family":"Mukai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-2525-4837","authenticated-orcid":false,"given":"Yuto","family":"Mitsui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5904-4882","authenticated-orcid":false,"given":"Toru","family":"Umehara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2103-1909","authenticated-orcid":false,"given":"Noriyuki","family":"Kijima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4248-2322","authenticated-orcid":false,"given":"Satoru","family":"Oshino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-7636-5833","authenticated-orcid":false,"given":"Masaharu","family":"Kohara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8490-3650","authenticated-orcid":false,"given":"Eiichi","family":"Morii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6289-3778","authenticated-orcid":false,"given":"Atsunori","family":"Fukuhara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0851-9603","authenticated-orcid":false,"given":"Iichiro","family":"Shimomura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,1]]},"reference":[{"key":"1714_CR1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2018-00975","author":"K Mukai","year":"2019","unstructured":"Mukai K, Otsuki M, Tamada D, Kitamura T, Hayashi R, Saiki A, Goto Y, Arita H, Oshino S, Morii E, Saitoh Y, Shimomura I (2019) Clinical characteristics of acromegalic patients with paradoxical GH response to oral glucose load. J Clin Endocrinol Metab. https:\/\/doi.org\/10.1210\/jc.2018-00975","journal-title":"J Clin Endocrinol Metab"},{"key":"1714_CR2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2012-1125","author":"H Arita","year":"2012","unstructured":"Arita H, Kinoshita M, Oshino S, Kitamura T, Otsuki M, Kasayama S, Shimokawa T, Shimomura I, Yoshimine T, Saitoh Y (2012) Biological characteristics of growth hormone-producing pituitary adenomas are different according to responsiveness to thyrotropin-releasing hormone. J Clin Endocrinol Metab. https:\/\/doi.org\/10.1210\/jc.2012-1125","journal-title":"J Clin Endocrinol Metab"},{"key":"1714_CR3","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-024-01410-2","author":"Y Mitsui","year":"2024","unstructured":"Mitsui Y, Mukai K, Otsuki M, Oshino S, Saitoh Y, Kohara M, Morii E, Fukuhara A, Shimomura I (2024) Growth hormone increase by luteinizing hormone-releasing hormone reflects gonadotroph-related characteristics in acromegaly. Pituitary. https:\/\/doi.org\/10.1007\/s11102-024-01410-2","journal-title":"Pituitary"},{"key":"1714_CR4","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2018-01360","author":"C Scaroni","year":"2019","unstructured":"Scaroni C, Albiger N, Daniele A, Dassie F, Romualdi C, Vazza G, Regazzo D, Ferra\u00f9 F, Barresi V, Maffeis V, Gardiman MP, Cannav\u00f2 S, Maffei P, Ceccato F, Losa M, Occhi G (2019) Paradoxical GH increase during OGTT is associated with first-generation somatostatin analog responsiveness in acromegaly. J Clin Endocrinol Metab. https:\/\/doi.org\/10.1210\/jc.2018-01360","journal-title":"J Clin Endocrinol Metab"},{"key":"1714_CR5","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-21-0324","author":"V Atquet","year":"2021","unstructured":"Atquet V, Alexopoulou O, Maiter D (2021) Characteristics and treatment responsiveness of patients with acromegaly and a paradoxical GH increase to oral glucose load. Eur J Endocrinol. https:\/\/doi.org\/10.1530\/EJE-21-0324","journal-title":"Eur J Endocrinol"},{"key":"1714_CR6","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-026-01649-x","author":"L De Marinis","year":"2026","unstructured":"De Marinis L, Chiloiro S, Mancini A, Giamb\u00f2 P, Giampietro A, Bianchi A, Pontecorvi A, Giustina A (2026) To test or not to test: what we have learnt from 50 years of dynamic testing in acromegaly. Pituitary. https:\/\/doi.org\/10.1007\/s11102-026-01649-x","journal-title":"Pituitary"},{"key":"1714_CR7","doi-asserted-by":"publisher","DOI":"10.1530\/eje.0.1310014","author":"A Colao","year":"1994","unstructured":"Colao A, Merola B, Ferone D, Calabrese MR, Longobardi S, Spaziante R, Di Renzo G, Annunziato L, Lombardi G (1994) Effect of corticotrophin-releasing hormone administration on growth hormone levels in acromegaly: in vivo and in vitro studies. Eur J Endocrinol. https:\/\/doi.org\/10.1530\/eje.0.1310014","journal-title":"Eur J Endocrinol"},{"key":"1714_CR8","doi-asserted-by":"publisher","DOI":"10.1007\/s12022-022-09703-7","author":"SL Asa","year":"2022","unstructured":"Asa SL, Mete O, Perry A, Osamura RY (2022) Overview of the 2022 WHO classification of pituitary tumors. Endocr Pathol. https:\/\/doi.org\/10.1007\/s12022-022-09703-7","journal-title":"Endocr Pathol"},{"key":"1714_CR9","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2014-2700","author":"L Katznelson","year":"2014","unstructured":"Katznelson L, Laws ER Jr., Melmed S, Molitch ME, Murad MH, Utz A, Wass JAH (2014) Acromegaly: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. https:\/\/doi.org\/10.1210\/jc.2014-2700","journal-title":"J Clin Endocrinol Metab"},{"key":"1714_CR10","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-023-01360-1","author":"A Giustina","year":"2024","unstructured":"Giustina A, Biermasz N, Casanueva FF, Fleseriu M, Mortini P, Strasburger C, van der Lely AJ, Wass J, Melmed S (2024) Consensus on criteria for acromegaly diagnosis and remission. Pituitary. https:\/\/doi.org\/10.1007\/s11102-023-01360-1","journal-title":"Pituitary"},{"key":"1714_CR11","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-31-3-239","author":"AM Lawrence","year":"1970","unstructured":"Lawrence AM, Goldfine ID, Kirsteins L (1970) Growth hormone dynamics in acromegaly. J Clin Endocrinol Metab. https:\/\/doi.org\/10.1210\/jcem-31-3-239","journal-title":"J Clin Endocrinol Metab"},{"key":"1714_CR12","doi-asserted-by":"publisher","DOI":"10.1507\/endocrj.EJ12-0110","author":"T Isojima","year":"2012","unstructured":"Isojima T, Shimatsu A, Yokoya S, Chihara K, Tanaka T, Hizuka N, Teramoto A, Tatsumi KI, Tachibana K, Katsumata N, Horikawa R (2012) Standardized centile curves and reference intervals of serum insulin-like growth factor-I (IGF-I) levels in a normal Japanese population using the LMS method. Endocr J. https:\/\/doi.org\/10.1507\/endocrj.EJ12-0110","journal-title":"Endocr J"},{"key":"1714_CR13","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-022-01284-2","author":"NF Lenders","year":"2022","unstructured":"Lenders NF, Chui J, Low J, Inder WJ, Earls PE, McCormack AI (2022) Development of a cost-effective diagnostic algorithm incorporating transcription factor immunohistochemistry in the evaluation of pituitary tumours. Pituitary. https:\/\/doi.org\/10.1007\/s11102-022-01284-2","journal-title":"Pituitary"},{"key":"1714_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2024.101893","author":"M Marazuela","year":"2024","unstructured":"Marazuela M, Mart\u00ednez-Hernandez R, Marques-Pamies M, Biagetti B, Araujo-Castro M, Puig-Domingo M (2024) Predictors of biochemical response to somatostatin receptor ligands in acromegaly. Best Pract Res Clin Endocrinol Metab. https:\/\/doi.org\/10.1016\/j.beem.2024.101893","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"1714_CR15","doi-asserted-by":"publisher","DOI":"10.1007\/s12022-008-9029-z","author":"A Obari","year":"2008","unstructured":"Obari A, Sano T, Ohyama K, Kudo E, Qian ZR, Yoneda A, Rayhan N, Mustafizur Rahman M, Yamada S (2008) Clinicopathological features of growth hormone-producing pituitary adenomas: difference among various types defined by cytokeratin distribution pattern including a transitional form. Endocr Pathol. https:\/\/doi.org\/10.1007\/s12022-008-9029-z","journal-title":"Endocr Pathol"},{"key":"1714_CR16","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgac512","author":"MD Ilie","year":"2022","unstructured":"Ilie MD, Tabarin A, Vasiljevic A, Bonneville JF, Moreau-Grang\u00e9 L, Schillo F, Delemer B, Barlier A, Figarella-Branger D, Bisot-Locard S, Santos A, Chanson P, Raverot G (2022) Predictive factors of somatostatin receptor ligand response in acromegaly\u2014a prospective study. J Clin Endocrinol Metab. https:\/\/doi.org\/10.1210\/clinem\/dgac512","journal-title":"J Clin Endocrinol Metab"},{"key":"1714_CR17","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2013-2145","author":"OC Borota","year":"2013","unstructured":"Borota OC, Heck A, Schulz S, Nesland JM, Ramm-Pettersen J, Lekva T, Alafuzoff I, Bollerslev J (2013) Expression of SSTR2a, but not of SSTRs 1, 3, or 5 in somatotroph adenomas assessed by monoclonal antibodies was reduced by octreotide and correlated with the acute and long-term effects of octreotide. J Clin Endocrinol Metab. https:\/\/doi.org\/10.1210\/jc.2013-2145","journal-title":"J Clin Endocrinol Metab"},{"key":"1714_CR18","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2011.04286.x","author":"A Heck","year":"2012","unstructured":"Heck A, Ringstad G, Fougner SL, Casar-Borota O, Nome T, Ramm-Pettersen J, Bollerslev J (2012) Intensity of pituitary adenoma on T2-weighted magnetic resonance imaging predicts the response to octreotide treatment in newly diagnosed acromegaly. Clin Endocrinol. https:\/\/doi.org\/10.1111\/j.1365-2265.2011.04286.x","journal-title":"Clin Endocrinol"},{"key":"1714_CR19","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2265.1998.3821204.x","author":"J Raza","year":"1998","unstructured":"Raza J, Massoud AF, Hindmarsh PC, Robinson IC, Brook CG (1998) Direct effects of corticotrophin-releasing hormone on stimulated growth hormone secretion. Clin Endocrinol (Oxf). https:\/\/doi.org\/10.1046\/j.1365-2265.1998.3821204.x","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1714_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/S0026-0495(96)90055-4","author":"T Ishizuka","year":"1995","unstructured":"Ishizuka T, Morita H, Mune T, Daidoh H, Hanafusa J, Yamamoto M, Shibata T, Yasuda K (1995) Growth hormone secretion in human acromegalic pituitary adenomas: cyclic adenosine monophosphate and protein kinase C responses. Metabolism. https:\/\/doi.org\/10.1016\/S0026-0495(96)90055-4","journal-title":"Metabolism"},{"key":"1714_CR21","doi-asserted-by":"publisher","DOI":"10.3390\/cells9040839","author":"L Vuppaladhadiam","year":"2020","unstructured":"Vuppaladhadiam L, Ehsan C, Akkati M, Bhargava A (2020) Corticotropin-releasing factor family: a stress hormone-receptor system\u2019s emerging role in mediating sex-specific signaling. Cells. https:\/\/doi.org\/10.3390\/cells9040839","journal-title":"Cells"},{"key":"1714_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/cells11233846","author":"J Rymuza","year":"2022","unstructured":"Rymuza J, Kober P, Rusetska N, Mossakowska BJ, Maksymowicz M, Nyc A, Baluszek S, Zieli\u0144ski G, Kunicki J, Bujko M (2022) Transcriptomic classification of pituitary neuroendocrine tumors causing acromegaly. Cells. https:\/\/doi.org\/10.3390\/cells11233846","journal-title":"Cells"},{"key":"1714_CR23","doi-asserted-by":"publisher","DOI":"10.1007\/s12022-023-09777-x","author":"SL Asa","year":"2023","unstructured":"Asa SL, Mete O, Riddle ND, Perry A (2023) Multilineage pituitary neuroendocrine tumors (PitNETs) expressing PIT1 and SF1. Endocr Pathol. https:\/\/doi.org\/10.1007\/s12022-023-09777-x","journal-title":"Endocr Pathol"},{"key":"1714_CR24","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-024-02686-1","author":"M Dottermusch","year":"2024","unstructured":"Dottermusch M, Ryba A, Ricklefs FL, Flitsch J, Schmid S, Glatzel M, Saeger W, Neumann JE, Sch\u00fcller U (2024) Pituitary neuroendocrine tumors with PIT1\/SF1 co-expression show distinct clinicopathological and molecular features. Acta Neuropathol. https:\/\/doi.org\/10.1007\/s00401-024-02686-1","journal-title":"Acta Neuropathol"},{"key":"1714_CR25","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22031043","author":"Y Lee","year":"2021","unstructured":"Lee Y, Ma EL, Patel M, Kim G, Howe C, Pothoulakis C, Kim YS, Im E, Rhee SH (2021) Corticotropin-releasing hormone receptor alters the tumor development and growth in Apcmin\/+ mice and in a chemically-induced model of colon cancer. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms22031043","journal-title":"Int J Mol Sci"},{"key":"1714_CR26","doi-asserted-by":"publisher","DOI":"10.1002\/mc.22691","author":"X Fang","year":"2017","unstructured":"Fang X, Hong Y, Dai L, Qian Y, Zhu C, Wu B, Li S (2017) CRH promotes human colon cancer cell proliferation via IL-6\/ JAK2\/ STAT3 signaling pathway and VEGF-induced tumor angiogenesis. Mol Carcinog. https:\/\/doi.org\/10.1002\/mc.22691","journal-title":"Mol Carcinog"},{"key":"1714_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.gastha.2022.09.003","author":"N Sato","year":"2022","unstructured":"Sato N, Motoi F, Tajiki H, Kawaguchi K, Ohtsuka H, Takadate T, Nakagawa K, Takagi K, Suzuki T, Katayose Y, Fukudo S, Unno M (2022) Expression of corticotropin-releasing hormone and its receptors may be associated with survival rate in pancreatic cancer. Gastro Hep Adv. https:\/\/doi.org\/10.1016\/j.gastha.2022.09.003","journal-title":"Gastro Hep Adv"},{"key":"1714_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmgh.2015.08.001","author":"JA Rodriguez","year":"2015","unstructured":"Rodriguez JA, Huerta-Yepez S, Law IKM, Baay-Guzman GJ, Tirado-Rodriguez B, Hoffman JM, Iliopoulos D, Hommes DW, Verspaget HW, Chang L, Pothoulakis C, Baritaki S (2015) Diminished expression of CRHR2 in human colon cancer promotes tumor growth and EMT via persistent IL-6\/Stat3 signaling. Cell Mol Gastroenterol Hepatol. https:\/\/doi.org\/10.1016\/j.jcmgh.2015.08.001","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"1714_CR29","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-024-01428-6","author":"N Sahakian","year":"2024","unstructured":"Sahakian N, Goetz L, Appay R, Graillon T, Raingeard I, Piazzola C, Regis J, Castinetti F, Brue T, Dufour H, Cuny T (2024) Outcome of non-functioning ACTH pituitary tumors: silent does not mean indolent. Pituitary. https:\/\/doi.org\/10.1007\/s11102-024-01428-6","journal-title":"Pituitary"}],"container-title":["Pituitary"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-026-01714-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11102-026-01714-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-026-01714-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T17:42:19Z","timestamp":1788457339000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11102-026-01714-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,1]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["1714"],"URL":"https:\/\/doi.org\/10.1007\/s11102-026-01714-5","relation":{},"ISSN":["1386-341X","1573-7403"],"issn-type":[{"value":"1386-341X","type":"print"},{"value":"1573-7403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,1]]},"assertion":[{"value":"20 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Ethics Committee of the University of Osaka (Approval No. 24451) and conducted in accordance with the Declaration of Helsinki.","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The requirement for written informed consent was waived by the Ethics Committee of the University of Osaka because of the retrospective nature of the study. Information regarding the present study was published on the department website to provide patients with an opportunity to opt out.","order":2,"name":"Ethics","label":"Consent","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"114"}}